Stay updated on SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The changes are limited to layout/formatting with no new eligibility criteria, endpoints, locations, or study status updated. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:17:51.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Version bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.
    Difference
    1%
    Check dated 2025-10-06T04:14:59.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-28T23:34:08.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. No substantive changes to core content, pricing, stock, or time-related information.
    Difference
    0.1%
    Check dated 2025-09-14T09:48:13.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T07:42:29.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, while also adding specific drug names such as Axatilimab and Durvalumab. Additionally, the revision number has been updated to v3.0.0.
    Difference
    0.8%
    Check dated 2025-08-31T00:47:44.000Z thumbnail image

Stay in the know with updates to SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.